A Study of Massage Therapy Alone and in Combination with Acupuncture for Breast Cancer Patients Undergoing Autologous Tissue Reconstruction


  • Study type

  • Study IDs

  • Describes the nature of a clinical study. Types include:

    • Observational study — observes people and measures outcomes without affecting results.
    • Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
    • Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
  • Site IRB
    • Rochester, Minnesota: 15-004621
    Sponsor Protocol Number: 15-004621

About this study

The purpose of this study is to explore the effectiveness of massage therapy combined with acupuncture in breast cancer patients recovering from autologous tissue reconstruction with the hope that the combination will augment the benefit obtained by massage therapy alone.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

See eligibility criteria

Inclusion Criteria

  • Female
  • Has breast cancer 
  • Will undergo a mastectomy and the following autologous tissue reconstruction
    • Free TRAM flaps (Transverse Rectus Abdominis Myocutaneous)
    • Muscle-sparing free TRAM flaps (or MS-TRAM)
    • DIEP flaps (Deep Inferior Epigastric Perforator)
    • SIEA flaps (Superficial Inferior Epigastric Artery)
    • Pedicled TRAM flaps
  • Will undergo surgery on Monday or Tuesday (massage or massage combined with acupuncture on postoperative days 1-3, plus or minus 1 day for beginning treatment)
  • Able to speak English
  • Able to complete the questionnaires
  • Sign informed consent

Exclusion Criteria

  • Taking anticoagulation medication (e.g. coumarin, heparin, warfarin)
  • Severe immunocompromised state

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Christina Dilaveri, M.D.

Closed for enrollment

Contact information:

Shawn Fokken CCRP



More information


Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available


Mayo Clinic Footer